Fig. 1From: Impact of highly active antiretroviral drug therapy (HAART) on biochemical, hematologic, atherogenic and anthropometric profiles of human immunodeficiency virus patients at a tertiary hospital in Owo, NigeriaNeutrophil/lymphocyte ratio of age-matched HIV-positive patients, HIV patients after a year of HAART and HIV-negative subjects. ***p < 0.001 versus HIV-positive; **p < 0.01 versus HIV-negative. HIV+ve HIV-positive group, HAART HIV-positive patients on HAART, HIV-negative HIV-negative group. The neutrophil/lymphocyte ratio was skewed by HIV infection, but the imbalance was ameliorated in patients on HAARTBack to article page